相关实验视频

Updated: May 28, 2025

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

基于β-葡萄糖的超吸收性水凝通过延迟胃排空,改善肠道屏障功能和调节肠道微生物群来改善与肥胖相关的代谢障碍

Yiming Jiang¹, Tingyi Zhou¹, Shiqi Zhang¹

¹State Key Laboratory of Food Science and Resources, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, PR China.

International journal of biological macromolecules

|February 11, 2025

概括

一种新的水凝通过减缓消化和改善肠道健康,有效地帮助减肥. 这种肥胖治疗显示出与塞马格卢提德相当的前景,提供了一种新的治疗选择.

科学领域:

生物材料科学生物材料科学
胃肠病学胃肠病学
代谢障碍代谢障碍代谢障碍

背景情况:

全球肥胖流行需要创新,有效和符合标准的减肥疗法.
与肥胖相关的代谢综合征需要新的治疗策略.

研究的目的:

为了研究一种新的,口服的基于β-葡萄糖的超吸收性水凝 (βC-MA水凝) 作为治疗肥胖和相关代谢障碍的非侵入性治疗方法.
评估βC-MA水凝对调节胃肠功能,肝脏健康,肠道炎症和肠道微生物群的疗效.

主要方法:

用βC-MA水凝来评估其对胃排空,营养吸收和体重的影响.
分析与肝脏中的脂质代谢相关的基因表达.
对炎症标记物 (TNF-α,IL-6) 和肠道屏障蛋白 (claudin-1,ZO-1,MUC2) 的测量.
评估肠道微生物群的组成和短链脂肪酸的产生.

主要成果:

βC-MA水凝显著降低了体重,脂肪积累,并改善了血糖和脂质水平.
水凝减缓了胃排空,减少了营养消化/吸收,并缓解了肝硬化和纤维化.
它降低了肠道炎症,增强了肠道屏障功能,并通过益生菌促进了有益的短链脂肪酸生产.

结论:

βC-MA水凝在对抗饮食引起的肥胖和代谢障碍方面表现出显著的有效性.
它的机制涉及调节消化,改善肠道健康和调节微生物群,提供了一个有希望的可食用的医疗设备.
疗效与塞马格卢提德相当,优于现有的干预措施.

关键词:

饮食纤维的食物纤维.我们的肠道微生物群.水凝是一种水凝.肠道屏障的功能是肠道屏障.肥胖问题肥胖问题体重管理体重管理

更多相关视频

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

相关概念视频

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

Glucose Absorption Into the Small Intestine

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...

Overview of Carbohydrate Metabolism

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...